세계의 비호르몬 피임 시장 보고서(2025년)

Non-hormonal contraceptives are methods used to prevent pregnancy without involving hormones that alter a woman's reproductive system. These contraceptives work by using physical barriers, chemical agents, or natural tracking techniques that do not interfere with the body's hormonal balance.

The primary categories of non-hormonal contraceptives include devices, sterilization, and others. Devices are physical tools or instruments designed to carry out specific functions, often applied in medical, industrial, or consumer settings. Their mechanisms may involve acting as antagonists, agonists, inhibitors, or modulators. These products can be administered via various routes such as intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal, and more. Their therapeutic purposes cover both disease treatment and symptom relief. The target conditions for these contraceptives include bacterial vaginosis, contraception, endometriosis, postmenopausal osteoporosis, uterine fibroids, vaginitis, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The non-hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides non-hormonal contraceptives market statistics, including non-hormonal contraceptives global market size, regional shares, competitors with non-hormonal contraceptives market share, detailed non-hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the non-hormonal contraceptives industry. The non-hormonal contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-hormonal contraceptives market size has grown strongly in recent years. It will grow from $23.73 billion in 2024 to $25.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be credited to increasing support for women's health initiatives, the expanding availability of over-the-counter non-hormonal contraceptive options, a heightened focus on developing male contraceptive products, rising demand for fertility-awareness-based contraceptive methods, and a growing number of product approvals and launches within the non-hormonal contraceptive market.

The non-hormonal contraceptives market size is expected to see strong growth in the next few years. It will grow to $33.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth expected in the forecast period is driven by rising demand for hormone-free birth control options, increased awareness of side effects linked to hormonal contraceptives, a growing preference for natural and chemical-free methods, the increasing prevalence of sexually transmitted infections, and heightened health consciousness among women about reproductive health. Key trends during this time include advancements in biomaterials for non-hormonal contraceptive devices, technological innovations in barrier contraceptive designs, the incorporation of smart tracking features with fertility-awareness techniques, progress in drug-free contraceptive gels and films, and the development of technology-enabled self-administration tools for contraceptive devices.

The rising prevalence of sexually transmitted diseases is expected to drive growth in the non-hormonal contraceptives market in the future. Sexually transmitted diseases (STDs) are infections primarily spread through sexual contact and caused by bacteria, viruses, or parasites. The increase in STDs is largely due to a decrease in condom use, which raises the risk of infection during unprotected sex. Non-hormonal contraceptives, such as male and female condoms, act as a physical barrier that prevents the exchange of bodily fluids during sexual activity, helping to reduce the transmission of STDs. For example, in April 2025, the Minnesota Department of Health (MDH), a US state health agency, reported that the proportion of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024. Thus, the growing prevalence of sexually transmitted diseases is contributing to the expansion of the non-hormonal contraceptives market.

Companies in the non-hormonal contraceptives market are focusing on innovative delivery systems such as preloaded intrauterine device (IUD) delivery systems to make insertion easier, increase user convenience, and improve clinical efficiency. A preloaded IUD delivery system combines the device and its inserter into a single, ready-to-use unit designed to simplify the insertion process, reduce setup time, and lower the risk of contamination or handling errors. For instance, in September 2024, CooperSurgical Inc., a US-based medical device and fertility company, launched the Paragard Single-Handed Inserter, which aims to improve insertion efficiency and patient comfort during non-hormonal IUD placement. The device provides over 99% effective, long-term birth control for up to 10 years by preventing sperm from fertilizing an egg. It offers immediate, reversible contraception without hormones and requires low maintenance after insertion.

In July 2022, Organon International, a US pharmaceutical company, partnered with Cirqle Biomedical Contraception ApS to develop and commercialize an innovative, non-hormonal, on-demand contraceptive. This collaboration aims to expand contraceptive options and address unmet needs in women's health. Cirqle Biomedical Contraception ApS is a Denmark-based life sciences company focused on creating non-hormonal contraceptive solutions for women.

Major players in the non-hormonal contraceptives market are Bayer AG., Church & Dwight Co., Mankind Pharma Limited, Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Natural Cycles Nordic AB, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Veru Inc., Evofem Biosciences Inc., Dare Bioscience Inc., Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, YourChoice Therapeutics Inc., Cirqle Biomedical Contraception ApS, Eppin Pharma Inc., Contraline Inc., and Linepharma International Ltd.

North America was the largest region in the non-hormonal contraceptives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in non-hormonal contraceptives report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-hormonal contraceptives market consists of sales of male condoms, copper intrauterine devices (IUDs), diaphragms, cervical caps, and spermicides. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Hormonal Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Devices; Sterilization; Other Product Types
• 2) By Mechanism Of Action: Antagonist; Agonist; Inhibitor; Modulator
• 3) By Route of Administration: Intramuscular; Intravaginal; Intravenous; Oral; Subcutaneous; Topical; Transdermal; Other Route Of Administrations
• 4) By Purpose Of Therapy: Treatment Of Disease; Management Of Symptoms
• 5) By Target Indication: Bacterial Vaginosis; Contraception; Endometriosis; Postmenopausal Osteoporosis; Uterine Fibroids; Vaginitis; Other Target Indications
• Subsegments:
• 1) By Devices: Surgical Instruments; Ligation Clips; Tubal Rings
• 2) By Sterilization: Permanent Sterilization; Reversible Sterilization; Mechanical Sterilization Devices
• 3) By Other Product Types: Non-Surgical Barrier Devices; Implantable Plugs; Intrauterine Permanent Devices
• Companies Mentioned: Bayer AG.; Church & Dwight Co.; Mankind Pharma Limited; Okamoto Industries; CooperSurgical Inc.; PSI India Pvt Ltd.; Karex Berhad; Natural Cycles Nordic AB; Fuji Latex Co. Ltd.; PREGNA INTERNATIONAL LTD.; Cupid Limited; Veru Inc.; Evofem Biosciences Inc.; Dare Bioscience Inc.; Global Protection Corp.; SMB Corporation of India; HLL Lifecare Limited; YourChoice Therapeutics Inc.; Cirqle Biomedical Contraception ApS; Eppin Pharma Inc.; Contraline Inc.; Linepharma International Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-Hormonal Contraceptives Market Characteristics

3. Non-Hormonal Contraceptives Market Trends And Strategies

4. Non-Hormonal Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non-Hormonal Contraceptives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Non-Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Non-Hormonal Contraceptives Market Growth Rate Analysis
• 5.4. Global Non-Hormonal Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Non-Hormonal Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Non-Hormonal Contraceptives Total Addressable Market (TAM)

6. Non-Hormonal Contraceptives Market Segmentation

• 6.1. Global Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Devices
• Sterilization
• Other Product Types
• 6.2. Global Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antagonist
• Agonist
• Inhibitor
• Modulator
• 6.3. Global Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular
• Intravaginal
• Intravenous
• Oral
• Subcutaneous
• Topical
• Transdermal
• Other Route of Administrations
• 6.4. Global Non-Hormonal Contraceptives Market, Segmentation By Purpose of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Of Disease
• Management Of Symptoms
• 6.5. Global Non-Hormonal Contraceptives Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Vaginosis
• Contraception
• Endometriosis
• Postmenopausal Osteoporosis
• Uterine Fibroids
• Vaginitis
• Other Target Indications
• 6.6. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Instruments
• Ligation Clips
• Tubal Rings
• 6.7. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Sterilization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Permanent Sterilization
• Reversible Sterilization
• Mechanical Sterilization Devices
• 6.8. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Surgical Barrier Devices
• Implantable Plugs
• Intrauterine Permanent Devices

7. Non-Hormonal Contraceptives Market Regional And Country Analysis

• 7.1. Global Non-Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Non-Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Hormonal Contraceptives Market

• 8.1. Asia-Pacific Non-Hormonal Contraceptives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Hormonal Contraceptives Market

• 9.1. China Non-Hormonal Contraceptives Market Overview
• 9.2. China Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Hormonal Contraceptives Market

• 10.1. India Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Hormonal Contraceptives Market

• 11.1. Japan Non-Hormonal Contraceptives Market Overview
• 11.2. Japan Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Hormonal Contraceptives Market

• 12.1. Australia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Hormonal Contraceptives Market

• 13.1. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Hormonal Contraceptives Market

• 14.1. South Korea Non-Hormonal Contraceptives Market Overview
• 14.2. South Korea Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Hormonal Contraceptives Market

• 15.1. Western Europe Non-Hormonal Contraceptives Market Overview
• 15.2. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Hormonal Contraceptives Market

• 16.1. UK Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Hormonal Contraceptives Market

• 17.1. Germany Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Hormonal Contraceptives Market

• 18.1. France Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Hormonal Contraceptives Market

• 19.1. Italy Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Hormonal Contraceptives Market

• 20.1. Spain Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Hormonal Contraceptives Market

• 21.1. Eastern Europe Non-Hormonal Contraceptives Market Overview
• 21.2. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Hormonal Contraceptives Market

• 22.1. Russia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Hormonal Contraceptives Market

• 23.1. North America Non-Hormonal Contraceptives Market Overview
• 23.2. North America Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Hormonal Contraceptives Market

• 24.1. USA Non-Hormonal Contraceptives Market Overview
• 24.2. USA Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Hormonal Contraceptives Market

• 25.1. Canada Non-Hormonal Contraceptives Market Overview
• 25.2. Canada Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Hormonal Contraceptives Market

• 26.1. South America Non-Hormonal Contraceptives Market Overview
• 26.2. South America Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Hormonal Contraceptives Market

• 27.1. Brazil Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Hormonal Contraceptives Market

• 28.1. Middle East Non-Hormonal Contraceptives Market Overview
• 28.2. Middle East Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Hormonal Contraceptives Market

• 29.1. Africa Non-Hormonal Contraceptives Market Overview
• 29.2. Africa Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Hormonal Contraceptives Market Competitive Landscape And Company Profiles

• 30.1. Non-Hormonal Contraceptives Market Competitive Landscape
• 30.2. Non-Hormonal Contraceptives Market Company Profiles
  • 30.2.1. Bayer AG. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Church & Dwight Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mankind Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Okamoto Industries Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CooperSurgical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Non-Hormonal Contraceptives Market Other Major And Innovative Companies

• 31.1. PSI India Pvt Ltd.
• 31.2. Karex Berhad
• 31.3. Natural Cycles Nordic AB
• 31.4. Fuji Latex Co. Ltd.
• 31.5. PREGNA INTERNATIONAL LTD.
• 31.6. Cupid Limited
• 31.7. Veru Inc.
• 31.8. Evofem Biosciences Inc.
• 31.9. Dare Bioscience Inc.
• 31.10. Global Protection Corp.
• 31.11. SMB Corporation of India
• 31.12. HLL Lifecare Limited
• 31.13. YourChoice Therapeutics Inc.
• 31.14. Cirqle Biomedical Contraception ApS
• 31.15. Eppin Pharma Inc.

32. Global Non-Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Hormonal Contraceptives Market

34. Recent Developments In The Non-Hormonal Contraceptives Market

35. Non-Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

• 35.1 Non-Hormonal Contraceptives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Non-Hormonal Contraceptives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Non-Hormonal Contraceptives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer